Cogstate (COGZ.F) Stock Overview
A neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
COGZ.F Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Cogstate Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.58 |
| 52 Week High | AU$2.10 |
| 52 Week Low | AU$0.69 |
| Beta | -0.055 |
| 1 Month Change | -1.25% |
| 3 Month Change | -4.24% |
| 1 Year Change | 115.08% |
| 3 Year Change | 17.91% |
| 5 Year Change | 64.07% |
| Change since IPO | 474.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| COGZ.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -7.1% | -0.9% | -0.4% |
| 1Y | 115.1% | -15.5% | 12.7% |
Return vs Industry: COGZ.F exceeded the US Healthcare Services industry which returned -15.5% over the past year.
Return vs Market: COGZ.F exceeded the US Market which returned 12.7% over the past year.
Price Volatility
| COGZ.F volatility | |
|---|---|
| COGZ.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 8.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: COGZ.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine COGZ.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 148 | Brad O'Connor | www.cogstate.com |
Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophrenia, oncology, safety, and sleep and mood disorders. The company also designs and provides quality assurance services in clinical trials focused on the administration, scoring, and recording of conventional brain health assessments.
Cogstate Limited Fundamentals Summary
| COGZ.F fundamental statistics | |
|---|---|
| Market cap | US$266.13m |
| Earnings (TTM) | US$10.14m |
| Revenue (TTM) | US$53.09m |
Is COGZ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COGZ.F income statement (TTM) | |
|---|---|
| Revenue | US$53.09m |
| Cost of Revenue | US$20.95m |
| Gross Profit | US$32.14m |
| Other Expenses | US$21.99m |
| Earnings | US$10.14m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Feb 18, 2026
| Earnings per share (EPS) | 0.059 |
| Gross Margin | 60.53% |
| Net Profit Margin | 19.11% |
| Debt/Equity Ratio | 0% |
How did COGZ.F perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/25 05:59 |
| End of Day Share Price | 2026/01/23 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cogstate Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Elyse Shapiro | Canaccord Genuity |
| Dennis Hulme | Taylor Collison Limited |
| Nicholas Lau | Taylor Collison Limited |